The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience

Background In dealing with community spread of COVID-19, two active interventions have been attempted or advocated—containment, and mitigation. Given the extensive impact of COVID-19 globally, there is international interest to learn from best practices that have been shown to work in controlling community spread to inform future outbreaks. This study explores the trajectory of COVID-19 infection in Singapore had the government intervention not focused on containment, but rather on mitigation. In addition, we estimate the actual COVID-19 infection cases in Singapore, given that confirmed cases are publicly available. Methods and findings We developed a COVID-19 infection model, which is a modified SIR model that differentiate between detected (diagnosed) and undetected (undiagnosed) individuals and segments total population into seven health states: susceptible (S), infected asymptomatic undiagnosed (A), infected asymptomatic diagnosed (I), infected symptomatic undiagnosed (U), infected symptomatic diagnosed (E), recovered (R), and dead (D). To account for the infection stages of the asymptomatic and symptomatic infected individuals, the asymptomatic infected individuals were further disaggregated into three infection stages: (a) latent (b) infectious and (c) non-infectious; while the symptomatic infected were disaggregated into two stages: (a) infectious and (b) non-infectious. The simulation result shows that by the end of the current epidemic cycle without considering the possibility of a second wave, under the containment intervention implemented in Singapore, the confirmed number of Singaporeans infected with COVID-19 (diagnosed asymptomatic and symptomatic cases) is projected to be 52,053 (with 95% confidence range of 49,370–54,735) representing 0.87% (0.83%-0.92%) of the total population; while the actual number of Singaporeans infected with COVID-19 (diagnosed and undiagnosed asymptomatic and symptomatic infected cases) is projected to be 86,041 (81,097–90,986), which is 1.65 times the confirmed cases and represents 1.45% (1.36%-1.53%) of the total population. A peak in infected cases is projected to have occurred on around day 125 (27/05/2020) for the confirmed infected cases and around day 115 (17/05/2020) for the actual infected cases. The number of deaths is estimated to be 37 (34–39) among those infected with COVID-19 by the end of the epidemic cycle; consequently, the perceived case fatality rate is projected to be 0.07%, while the actual case fatality rate is estimated to be 0.043%. Importantly, our simulation model results suggest that there about 65% more COVID-19 infection cases in Singapore that have not been captured in the official reported numbers which could be uncovered via a serological study. Compared to the containment intervention, a mitigation intervention would have resulted in early peak infection, and increase both the cumulative confirmed and actual infection cases and deaths. Conclusion Early public health measures in the context of targeted, aggressive containment including swift and effective contact tracing and quarantine, was likely responsible for suppressing the number of COVID-19 infections in Singapore.

[1]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[2]  Yongsheng Wu,et al.  Evolving Epidemiology and Effect of Non-pharmaceutical Interventions on the Epidemic of Coronavirus Disease 2019 in Shenzhen, China , 2020, medRxiv.

[3]  Brian A. King,et al.  COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. , 2020, JAMA.

[4]  P. Colaneri,et al.  Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy , 2020, Nature Medicine.

[5]  R. Walensky,et al.  From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle. , 2020, JAMA.

[6]  Chonggang Xu,et al.  High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Emerging infectious diseases.

[7]  M. Day Covid-19: four fifths of cases are asymptomatic, China figures indicate , 2020, BMJ.

[8]  L. Luo,et al.  Modes of contact and risk of transmission in COVID-19 among close contacts , 2020, medRxiv.

[9]  Benjamin Er,et al.  Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[10]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[11]  Zheng Zhao,et al.  Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures , 2020, The Lancet.

[12]  Francesco Casella Can the COVID-19 epidemic be managed on the basis of daily data? , 2020, ArXiv.

[13]  M. Lipsitch,et al.  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[14]  Stephen M Parodi,et al.  From Containment to Mitigation of COVID-19 in the US. , 2020, JAMA.

[15]  Lucie Abeler-Dörner,et al.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.

[16]  Liang Peng,et al.  Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report , 2020, International Journal of Infectious Diseases.

[17]  Yongli Cai,et al.  A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action , 2020, International Journal of Infectious Diseases.

[18]  P. Klepac,et al.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.

[19]  Dan Xu,et al.  Positive RT-PCR Test Results in Patients Recovered From COVID-19. , 2020, JAMA.

[20]  A. Tamin,et al.  Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus , 2016, Emerging infectious diseases.

[21]  Lin‐Fa Wang,et al.  Duration of Antibody Responses after Severe Acute Respiratory Syndrome , 2007, Emerging infectious diseases.

[22]  Stefan Ma,et al.  Epidemiology and control of SARS in Singapore. , 2006, Annals of the Academy of Medicine, Singapore.

[23]  L James,et al.  Public health measures implemented during the SARS outbreak in Singapore, 2003. , 2006, Public health.

[24]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .